BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11726923)

  • 1. Mutation of the ST7 tumor suppressor gene on 7q31.1 is rare in breast, ovarian and colorectal cancers.
    Thomas NA; Choong DY; Jokubaitis VJ; Neville PJ; Campbell IG
    Nat Genet; 2001 Dec; 29(4):379-80. PubMed ID: 11726923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of ST7 gene alterations in human cancer.
    Dong SM; Sidransky D
    Clin Cancer Res; 2002 Sep; 8(9):2939-41. PubMed ID: 12231539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of mutations within ST7 gene in tumour-derived cell lines and primary epithelial tumours.
    Brown VL; Proby CM; Barnes DM; Kelsell DP
    Br J Cancer; 2002 Jul; 87(2):208-11. PubMed ID: 12107844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31.
    Zenklusen JC; Conti CJ; Green ED
    Nat Genet; 2001 Apr; 27(4):392-8. PubMed ID: 11279520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of ST7 mutations in tumor-derived cell lines and tumors.
    Hughes KA; Hurlstone AF; Tobias ES; McFarlane R; Black DM
    Nat Genet; 2001 Dec; 29(4):380-1. PubMed ID: 11726924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An LOH and mutational investigation of the ST7 gene locus in human esophageal carcinoma.
    Wang S; Mori Y; Sato F; Yin J; Xu Y; Zou TT; Olaru A; Kimos MC; Perry K; Selaru FM; Deacu E; Sun M; Shi YC; Shibata D; Abraham JM; Greenwald BD; Meltzer SJ
    Oncogene; 2003 Jan; 22(3):467-70. PubMed ID: 12545169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and epigenetic analysis of the putative tumor suppressor km23 in primary ovarian, breast, and colorectal cancers.
    Campbell IG; Phillips WA; Choong DY
    Clin Cancer Res; 2006 Jun; 12(12):3713-5. PubMed ID: 16778097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the ST7 gene in human myeloid tumor cell lines.
    Sivasundaram K; Suzuki H; Seto M; Hosokawa Y
    Oncol Rep; 2003; 10(6):1737-9. PubMed ID: 14534688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning and characterization of ST7R (ST7-like, ST7L) on human chromosome 1p13, a novel gene homologous to tumor suppressor gene ST7 on human chromosome 7q31.
    Katoh M
    Int J Oncol; 2002 Jun; 20(6):1247-53. PubMed ID: 12012006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer.
    Liu MC; Choong DY; Hooi CS; Williams LH; Campbell IG
    Cancer Lett; 2007 Mar; 247(1):91-7. PubMed ID: 16644110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the PIK3CA gene in ovarian and breast cancer.
    Campbell IG; Russell SE; Choong DY; Montgomery KG; Ciavarella ML; Hooi CS; Cristiano BE; Pearson RB; Phillips WA
    Cancer Res; 2004 Nov; 64(21):7678-81. PubMed ID: 15520168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 7q31 allelic imbalance and somatic mutations of RAY1/ST7 gene in colorectal cancer.
    Haddad R; Vincent JB; Gryfe R; Kim H; Wen J; Redston M; Scherer SW; Gallinger S
    Cancer Lett; 2004 Jan; 203(1):87-90. PubMed ID: 14670621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix.
    Hooi CF; Blancher C; Qiu W; Revet IM; Williams LH; Ciavarella ML; Anderson RL; Thompson EW; Connor A; Phillips WA; Campbell IG
    Oncogene; 2006 Jun; 25(28):3924-33. PubMed ID: 16474848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientists find new tumor suppressor gene involved in breast, prostate, and other cancers.
    J Am Coll Surg; 2001 Jun; 192(6):806. PubMed ID: 11400979
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutation analysis of EP300 in colon, breast and ovarian carcinomas.
    Bryan EJ; Jokubaitis VJ; Chamberlain NL; Baxter SW; Dawson E; Choong DY; Campbell IG
    Int J Cancer; 2002 Nov; 102(2):137-41. PubMed ID: 12385008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
    Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
    Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.
    Lu C; Xu HM; Ren Q; Ao Y; Wang ZN; Ao X; Jiang L; Luo Y; Zhang X
    World J Gastroenterol; 2003 Dec; 9(12):2662-5. PubMed ID: 14669308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
    Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
    Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.